IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

STACCHIOTTI, SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.816
NA - Nord America 5.669
AS - Asia 4.339
Continente sconosciuto - Info sul continente non disponibili 464
SA - Sud America 382
AF - Africa 145
OC - Oceania 28
Totale 16.843
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.419
DE - Germania 2.153
CN - Cina 1.258
SG - Singapore 1.070
IT - Italia 1.032
GB - Regno Unito 893
BD - Bangladesh 550
HK - Hong Kong 435
SE - Svezia 319
BR - Brasile 272
VN - Vietnam 269
RU - Federazione Russa 228
IN - India 225
FR - Francia 206
NL - Olanda 191
ES - Italia 166
CA - Canada 157
FI - Finlandia 151
JP - Giappone 115
IE - Irlanda 108
ID - Indonesia 83
KR - Corea 57
TR - Turchia 52
BE - Belgio 50
DK - Danimarca 48
CI - Costa d'Avorio 47
AT - Austria 40
MX - Messico 38
AR - Argentina 37
CH - Svizzera 37
PL - Polonia 35
TW - Taiwan 34
PH - Filippine 31
ZA - Sudafrica 31
UA - Ucraina 28
PK - Pakistan 26
PT - Portogallo 26
AU - Australia 25
IQ - Iraq 25
GR - Grecia 22
CO - Colombia 21
SI - Slovenia 21
UG - Uganda 19
IL - Israele 17
PE - Perù 16
SA - Arabia Saudita 15
CL - Cile 14
JM - Giamaica 13
NO - Norvegia 13
RO - Romania 13
UZ - Uzbekistan 13
EG - Egitto 12
EC - Ecuador 11
MY - Malesia 8
AE - Emirati Arabi Uniti 7
JO - Giordania 7
TH - Thailandia 7
CR - Costa Rica 6
PA - Panama 6
SK - Slovacchia (Repubblica Slovacca) 6
DO - Repubblica Dominicana 5
GT - Guatemala 5
NG - Nigeria 5
TN - Tunisia 5
VE - Venezuela 5
AL - Albania 4
BG - Bulgaria 4
HN - Honduras 4
NP - Nepal 4
TT - Trinidad e Tobago 4
ZW - Zimbabwe 4
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
CZ - Repubblica Ceca 3
HR - Croazia 3
HU - Ungheria 3
IR - Iran 3
KE - Kenya 3
KZ - Kazakistan 3
LK - Sri Lanka 3
MA - Marocco 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
OM - Oman 3
PY - Paraguay 3
QA - Qatar 3
SV - El Salvador 3
TZ - Tanzania 3
AM - Armenia 2
AP - ???statistics.table.value.countryCode.AP??? 2
BO - Bolivia 2
BY - Bielorussia 2
CM - Camerun 2
DZ - Algeria 2
HT - Haiti 2
KG - Kirghizistan 2
KW - Kuwait 2
LC - Santa Lucia 2
LT - Lituania 2
PR - Porto Rico 2
Totale 16.358
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 1.915
Southend 746
Singapore 635
Ashburn 614
Hong Kong 366
Chandler 345
Fairfield 328
San Jose 256
Milan 233
Beijing 200
Santa Clara 190
Houston 182
Woodbridge 150
Seattle 145
Council Bluffs 140
Redwood City 137
Los Angeles 127
Wilmington 127
Helsinki 126
New York 116
Dallas 107
Dublin 105
Ann Arbor 104
Cambridge 101
Dearborn 96
Princeton 96
Ho Chi Minh City 95
Bengaluru 91
Rome 78
Shanghai 74
Redmond 72
Nanjing 71
Guangzhou 69
Jakarta 68
Buffalo 66
Hanoi 65
Phoenix 64
Moscow 62
Boardman 61
Ilion 60
Tokyo 57
Lauterbourg 56
Abidjan 47
Madrid 45
Des Moines 44
Columbus 43
The Dalles 39
Toronto 39
Bologna 36
Hefei 36
Chattanooga 35
Munich 34
Reno 33
São Paulo 33
Central District 32
Jinan 31
Chicago 30
London 30
Seoul 30
Tianjin 29
Cangzhou 28
Istanbul 28
Skokie 28
Sacramento 27
San Francisco 27
Turin 27
Naples 26
Nuremberg 26
Taipei 26
Atlanta 24
Washington 23
Hangzhou 22
Nanchang 22
Shenzhen 22
Baltimore 21
Barcelona 21
Shenyang 21
Changsha 20
Mumbai 20
Amsterdam 19
Lubbock 19
Ottawa 19
Philadelphia 19
San Diego 19
Warsaw 18
Brussels 17
Fuzhou 17
Ljubljana 16
Montreal 16
Paris 16
Twentynine Palms 16
Appleton 15
Boston 15
Kampala 15
Palermo 15
Athens 14
Johannesburg 14
Catania 13
Charlotte 13
Delhi 13
Totale 10.239
Salva come PNG Salva come JPEG
Nome #
The Activity of Chemotherapy in Inflammatory Myofibroblastic Tumors : A Multicenter, European Retrospective Case Series Analysis 850
Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up 849
Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up 738
High-grade soft-tissue sarcomas: Tumor response assessment - Pilot study to assess the correlation between radiologic and pathologic response by using RECIST and Choi criteria 662
Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up 551
Community-based rehabilitation program for cerebral PALSY (CP) children in North Uganda 466
Primary extremity soft tissue sarcomas: Outcome improvement over time at a single institution 386
How a Clinical Trial Unit can improve independent clinical research in rare tumors: the Italian Sarcoma Group experience 359
Solitary fibrous tumour presenting with a single bone metastasis : report of six cases and literature review 347
NR4A3 fusion proteins trigger an axon guidance switch that marks the difference between EWSR1 and TAF15 translocated extraskeletal myxoid chondrosarcomas 338
Response to sunitinib malate in advanced alveolar soft part sarcoma 325
Best practices for the management of local-regional recurrent chordoma : a position paper by the Chordoma Global Consensus Group 324
Anthracycline-based chemotherapy in extraskeletal myxoid chondrosarcoma: a retrospective study 297
Epithelioid hemangioendothelioma, an ultra-rare cancer : a consensus paper from the community of experts 296
Role of chemotherapy, VEGFR inhibitors and mTOR Inhibitors in advanced Perivascular Epithelioid Cell Tumours (PEComas) 294
High-Dose Ifosfamide Chemotherapy in a Series of Patients Affected by Myxoid Liposarcoma 285
Imatinib mesylate in chordoma 284
CINSARC in high-risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the ISG-STS 1001 study 272
Identification of SRF-E2F1 fusion transcript in EWSR-negative myoepithelioma of the soft tissue 263
Adaptive Immunity in Fibrosarcomatous Dermatofibrosarcoma Protuberans and Response to Imatinib Treatment 260
Radiation-induced sarcoma of the head and neck: A review of the literature 256
Solitary fibrous tumor of all sites: outcome of late recurrences in 14 patients 255
Completion surgery of residual disease after primary inadequate surgery of retroperitoneal sarcomas can salvage a selected subgroup of patients—A propensity score analysis 251
Identification of an actionable mutation of kit in a case of extraskeletal myxoid chondrosarcoma 245
Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS) : long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group 243
Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma 242
Rechallenge of denosumab in advanced giant cell tumor of the bone after atypical femur fracture: A case report and review of literature 240
Anthracycline, gemcitabine, and pazopanib in epithelioid sarcoma : a multi-institutional case series 237
Activity of axitinib in progressive advanced solitary fibrous tumour: Results from an exploratory, investigator-driven phase 2 clinical study 236
Analysis of receptor tyrosine kinases (RTKs) and downstream pathways in chordomas 234
The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma : revisiting the results of the EORTC-STBSG 62931 randomised trial 234
Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour 232
Pazopanib for treatment of typical solitary fibrous tumours : a multicentre, single-arm, phase 2 trial 224
Clinical prognostic factors in advanced epithelioid haemangioendothelioma : a retrospective case series analysis within the Italian Rare Cancers Network 224
Prolonged activity and toxicity of sirolimus in a patient with metastatic renal perivascular epithelioid cell tumor : a case report and literature review 219
High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trial 218
Response to imatinib in villonodular pigmented synovitis (PVNS) resistant to nilotinib 217
Genome-wide analysis identifies MEN1 and MAX mutations and a neuroendocrine-like molecular heterogeneity in Quadruple WT GIST 216
Rechallenge of denosumab in jaw osteonecrosis of patients with unresectable giant cell tumour of bone: A case series analysis and literature review 212
Selinexor versus doxorubicin in dedifferentiated liposarcoma PDXs: evidence of greater activity and apoptotic response dependent on p53 nuclear accumulation and survivin down‐regulation 211
Impact of perioperative chemotherapy and radiotherapy in patients with primary extremity soft tissue sarcoma: retrospective analysis across major histological subtypes and major reference centres 210
High-grade sarcomatous overgrowth in solitary fibrous tumors : a clinicopathologic study of 10 cases 205
Evidence for PDGFRA, PDGFRB and KIT deregulation in an NSCLC patient [3] 201
Imatinib and everolimus in patients with progressing advanced chordoma: A phase 2 clinical study 196
Long-term survivors with desmoplastic small round cell tumor (DSRCT): Results from a retrospective single-institution case series analysis 191
Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study 187
Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour : a multicentre, single-arm, phase 2 trial 181
Peripheral Inflammatory Indexes Neutrophil/Lymphocyte Ratio (NLR) and Red Cell Distribution Width (RDW) as Prognostic Biomarkers in Advanced Solitary Fibrous Tumour (SFT) Treated with Pazopanib 180
Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients 175
Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial 163
Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up ☆ 150
Systemic therapies in advanced epithelioid haemangioendothelioma: A retrospective international case series from the World Sarcoma Network and a review of literature 145
HSPA8 as a novel fusion partner of NR4A3 in extraskeletal myxoid chondrosarcoma 141
Unplanned Excision of Extremity and Trunk Wall Soft Tissue Sarcoma: To Re-resect or Not to Re-resect? 133
(Neo)adjuvant treatment in localised soft tissue sarcoma: The unsolved affair 126
Neoadjuvant chemotherapy in high-risk soft tissue sarcomas : Final results of a randomized trial from Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) sarcoma groups 124
A Prospective Observational Study of Active Surveillance in Primary Desmoid Fibromatosis 123
Extended molecular profiling in mesenchymal tumors: a consensus paper from the Italian Sarcoma Group 117
Neoadjuvant treatment: A novel standard? 116
Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG) 110
The observational EURACAN prospective clinical registry dedicated to epithelioid hemangioendothelioma: The protocol of an international and collaborative effort on an ultra-rare entity 87
Histopathological Response After Neoadjuvant Chemotherapy for High-Risk Soft-Tissue Sarcomas: A Secondary Analysis of a Randomized Clinical Trial 82
Clinical recommendations for treatment of localized angiosarcoma: A consensus paper by the Italian Sarcoma Group 79
Redefining radiologic responses in high-risk soft-tissue sarcomas treated with neoadjuvant chemotherapy: final results of ISG-STS 1001, a randomized clinical trial 75
GDF-15 Predicts Epithelioid Hemangioendothelioma Aggressiveness and Is Downregulated by Sirolimus through ATF4/ATF5 Suppression 62
Guidelines for Next-Generation Sequencing in Sarcoma Diagnosis and Treatment: A Consensus Review 55
Outcome improvement with chemotherapy and radiotherapy in primary, localized, radiation-associated angiosarcoma of the breast region: a retrospective case series analysis 48
Pathological and radiological response following neoadjuvant treatments in primary localized resectable myxofibrosarcoma and undifferentiated pleomorphic sarcoma of the extremities and trunk wall 40
Regorafenib in advanced solitary fibrous tumour: Results from an exploratory phase II clinical study 34
null 12
null 3
Totale 16.843
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.466
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.466
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022750 0 92 49 46 61 38 55 47 59 64 54 185
2022/20231.128 133 114 102 133 121 153 42 69 143 24 71 23
2023/20242.134 45 62 49 64 203 93 319 284 139 269 296 311
2024/20252.429 261 266 198 248 155 112 79 174 108 203 224 401
2025/20265.094 409 214 282 273 345 347 688 257 567 315 720 677
2026/20271.076 961 115 0 0 0 0 0 0 0 0 0 0
Totale 16.843